Stock Events

Stock Events

Towa Pharmaceutical. 

$16.83
5
-$8.5-33.56% Monday 20:00

Statistics

Day High
25.33
Day Low
25.33
52W High
25.33
52W Low
16.83
Volume
200
Avg. Volume
0
Mkt Cap
867.01M
P/E Ratio
6.28
Dividend Yield
1.5%
Dividend
0.25

Upcoming

29
SEP
Dividend Ex
Estimated
 
1
DEC
Dividend Payment
Estimated
 
30
MAR 27
Dividend Ex
Estimated
 
29
SEP 27
Dividend Ex
Estimated
 
1
DEC 27
Dividend Payment
Estimated
 

Dividends

1.5%Dividend Yield
Mar 26
$0.25
Dec 25
$0.27
Jun 25
$0.27
Dec 24
$0.21
Jun 24
$0.2
10Y Growth
9.71%
5Y Growth
11.7%
3Y Growth
10.06%
1Y Growth
N/A

Earnings

14MayExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
0.14
0.43
0.71
1
Expected EPS
0.8723376279893467
Actual EPS
N/A

Financials

7.29%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
3.5BRevenue
255.23MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow TWAPF. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
OtsukaLtd.
OTSKY
Mkt Cap28.73B
Otsuka Holdings Co., Ltd. operates in the same pharmaceutical sector, focusing on innovative and generic drug development, directly competing with Towa Pharmaceutical's market.
Chugai Pharmaceutical
CHGCY
Mkt Cap75.37B
Chugai Pharmaceutical Co., Ltd. is known for its biopharmaceuticals and therapeutic products, competing in the same space as Towa Pharmaceutical, especially in Japan.
Santen Pharmaceutical.
SNPHY
Mkt Cap3.24B
Santen Pharmaceutical Co., Ltd. specializes in ophthalmic products but also has a broad range of pharmaceutical products that compete with Towa Pharmaceutical's offerings.
Takeda Pharmaceutical
TKPHF
Mkt Cap43.8B
Teikoku Pharma USA, Inc., a subsidiary of Teikoku Seiyaku Co., Ltd., competes in the development and manufacturing of pharmaceutical products, including generics, similar to Towa Pharmaceutical.
Asahi Kasei
AHKSY
Mkt Cap10.43B
Astellas Pharma Inc. is a global pharmaceutical company that competes with Towa Pharmaceutical in developing and marketing pharmaceutical products for various therapeutic areas.
Takeda Pharmaceutical
TAK
Mkt Cap42.62B
Takeda Pharmaceutical Company Limited operates globally in the pharmaceutical sector, offering a wide range of products that compete with Towa Pharmaceutical's portfolio.
Merck
MRK
Mkt Cap214.76B
Merck & Co., Inc., while based in the US, has a significant global presence and competes in various therapeutic areas covered by Towa Pharmaceutical.
Pfizer
PFE
Mkt Cap140.15B
Pfizer Inc. is a global pharmaceutical giant that competes across a broad range of therapeutic areas, including those targeted by Towa Pharmaceutical.

About

Towa Pharmaceutical Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells ethical drugs, active pharmaceutical ingredients, and intermediates in Japan. The company provides its products in the therapeutic areas of diabetes, digestive system, nervous system, and allergic diseases, as well as vitamins, antibiotics, and oncology products. It had a portfolio of approximately 700 drug products. Towa Pharmaceutical Co., Ltd. was founded in 1951 and is headquartered in Osaka, Japan.
Show more...
CEO
Mr. Itsuro Yoshida
Employees
4588
Country
JP
ISIN
JP3623150004

Listings

TSE
JP
4553.TSE
OTC Link
US
TWAPF
F
DE
6QC.F

0 Comments

Share your thoughts

FAQ

What is Towa Pharmaceutical. stock price today?▼
The current price of TWAPF is $16.83 USD — it has decreased by -33.56% in the past 24 hours. Watch Towa Pharmaceutical. stock price performance more closely on the chart.
What is Towa Pharmaceutical. stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Towa Pharmaceutical. stocks are traded under the ticker TWAPF.
What is Towa Pharmaceutical. market cap?▼
Today Towa Pharmaceutical. has the market capitalization of 867.01M
When is the next Towa Pharmaceutical. earnings date?▼
Towa Pharmaceutical. is going to release the next earnings report on May 14, 2026.
What were Towa Pharmaceutical. earnings last quarter?▼
TWAPF earnings for the last quarter are 1.15 USD per share, whereas the estimation was 0.47 USD resulting in a +144.9% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Towa Pharmaceutical. revenue for the last year?▼
Towa Pharmaceutical. revenue for the last year amounts to 3.5B USD.
What is Towa Pharmaceutical. net income for the last year?▼
TWAPF net income for the last year is 255.23M USD.
Does Towa Pharmaceutical. pay dividends?▼
Yes, TWAPF dividends are paid semi-annual. The last dividend per share was 0.25 USD. As of today, Dividend Yield (FWD)% is 1.5%.
How many employees does Towa Pharmaceutical. have?▼
As of April 02, 2026, the company has 4,588 employees.
In which sector is Towa Pharmaceutical. located?▼
Towa Pharmaceutical. operates in the Health Care sector.
When did Towa Pharmaceutical. complete a stock split?▼
The last stock split for Towa Pharmaceutical. was on March 27, 2019 with a ratio of 3:1.
Where is Towa Pharmaceutical. headquartered?▼
Towa Pharmaceutical. is headquartered in Osaka, JP.